A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris.

Trial Profile

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2017

At a glance

  • Drugs E 6201 (Primary) ; Calcipotriol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 22 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2009-014815-11).
    • 05 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top